Bárbara Martins Saraiva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bárbara Martins Saraiva has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Ana Margarida Garcia
Pediatric Infectiology Unit, Hospital Dona Estefânia, Local Health Unit of São José, Lisbon, Portugal
3 shared publications- Afonso Sousa
Hospital Dona Estefânia, Unidade Local de Saúde São José, 1169-045 Lisbon, Portugal
2 shared publications - Anaxore Casimiro
Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa
2 shared publications - Beatriz Luzio Vaz
Hospital Dona Estefânia, Unidade Local de Saúde de São José, 1169-045 Lisboa, Portugal
2 shared publications Catarina Gouveia
Pediatric Infectiology Unit, Hospital Dona Estefânia, Local Health Unit of São José, Lisbon, Portugal
2 shared publications- Isabel Craveiro
Universidade Nova de Lisboa
2 shared publications
Latest Publications
- Open Access
Characteristics of Anemia in Children Aged 6 Months to 5 Years Attending External Consultations at a Pediatric Hospital in Lisbon, Portugal
Background/Objectives: Childhood anemia remains a serious public health issue, negatively affecting cognitive and psychomotor development, with repercussions on school performance and adult productivity. This study aimed to characterize the profile of children aged 6 months to 5 years diagnosed with or at risk of anemia who attended a pediatric hospital in Lisbon, Portugal. Methods: A hospital-based, cross-sectional descriptive study was conducted from September 2023 to September 2024. Descriptive statistics, including frequency distributions and cross-tabulations, summarized participant characteristics and key variables. Results: We observed that 33.3% (74/222) of the children were either anemic or at risk of anemia. Among these, 93.2% (69/74) were confirmed anemic or at risk based on hemoglobin levels. Five children (6.8%) had normal hemoglobin but abnormal red-cell indices, with microcytic (60.0%; 3/5) or normocytic (40.0%; 2/5) patterns. Anemia rates were higher in males (55.1%), children aged 24–59 months, those residing in the Metropolitan Lisbon Area (82.6%), children whose caregivers had only basic or secondary education (58.0%), and those whose mothers were born in foreign countries (48.4%). Microcytic red-cell indices were observed in 63.1% of cases. Serum iron results indicated that 32.0% were pre-anemic and 40.0% anemic. Ferritin levels showed iron-deficiency anemia in 22.2% of tested cases. In addition, 33.3% carried the sickle cell trait, and 35.0% had elevated C-reactive protein, suggesting anemia of inflammation. Conclusions: Anemia is a moderate public health issue, mainly affecting children with less-educated caregivers and migrant mothers. Targeted public health actions, including systematic screening, caregiver education, and multiculturally sensitive interventions, are crucial to address anemia.
Open AccessCharacteristics of Anemia in Children Aged 6 Months to 5 Years Attending External Consultations at a Pediatric Hospital in Lisbon, Portugal
Background/Objectives: Childhood anemia remains a serious public health issue, negatively affecting cognitive and psychomotor development, with repercussions on school performance and adult productivity. This study aimed to characterize the profile of children aged 6 months to 5 years diagnosed with or at risk of anemia who attended a pediatric hospital in Lisbon, Portugal. Methods: A hospital-based, cross-sectional descriptive study was conducted from September 2023 to September 2024. Descriptive statistics, including frequency distributions and cross-tabulations, summarized participant characteristics and key variables. Results: We observed that 33.3% (74/222) of the children were either anemic or at risk of anemia. Among these, 93.2% (69/74) were confirmed anemic or at risk based on hemoglobin levels. Five children (6.8%) had normal hemoglobin but abnormal red-cell indices, with microcytic (60.0%; 3/5) or normocytic (40.0%; 2/5) patterns. Anemia rates were higher in males (55.1%), children aged 24–59 months, those residing in the Metropolitan Lisbon Area (82.6%), children whose caregivers had only basic or secondary education (58.0%), and those whose mothers were born in foreign countries (48.4%). Microcytic red-cell indices were observed in 63.1% of cases. Serum iron results indicated that 32.0% were pre-anemic and 40.0% anemic. Ferritin levels showed iron-deficiency anemia in 22.2% of tested cases. In addition, 33.3% carried the sickle cell trait, and 35.0% had elevated C-reactive protein, suggesting anemia of inflammation. Conclusions: Anemia is a moderate public health issue, mainly affecting children with less-educated caregivers and migrant mothers. Targeted public health actions, including systematic screening, caregiver education, and multiculturally sensitive interventions, are crucial to address anemia.
- Open Access
- 6 May 2025
- Published by MDPI AG in Preprints.org
Characteristics of Anemia in Children Aged 6 Months to 5 Years Attending a Pediatric Hospital in Lisbon, Portugal
Childhood anemia is a serious public health issue that adversely affects cognitive and psychomotor development, impacting school performance and adult productivity. In this cross-sectional descriptive study, we characterized the profile of children aged 6 months to 5 years diagnosed with or at risk of anemia while attending consultations at a pediatric hospital in Lisbon, Portugal. We found that 33.3% (74/222) of the children were either anemic or at risk of developing anemia. The overall anemia rates based on hemoglobin levels were 54.5% for mild anemia (36/66), 34.8% for moderate anemia (23/66), and 10.6% for borderline anemia (7/66). More than half (64/70) of the children had microcytic anemia, while 8.6% (6/70) had normocytic anemia. About 40.0% (12/30) of the children had iron deficiency anemia, and 33.3 % (3/9) had sickle cell trait. Our results indicate that anemia rates were higher in male children aged 2-3 years, those whose caregivers had a low level of education, and those whose mothers were from the Community of Portuguese Language Countries. Further research, including analytical cross-sectional or longitudinal studies, is necessary to explore the impact of feeding practices, dietary habits, and socioeconomic and metabolic factors on childhood anemia.
- 6 May 2025
- Published by MDPI AG in Preprints.org
Open AccessCharacteristics of Anemia in Children Aged 6 Months to 5 Years Attending a Pediatric Hospital in Lisbon, Portugal
Childhood anemia is a serious public health issue that adversely affects cognitive and psychomotor development, impacting school performance and adult productivity. In this cross-sectional descriptive study, we characterized the profile of children aged 6 months to 5 years diagnosed with or at risk of anemia while attending consultations at a pediatric hospital in Lisbon, Portugal. We found that 33.3% (74/222) of the children were either anemic or at risk of developing anemia. The overall anemia rates based on hemoglobin levels were 54.5% for mild anemia (36/66), 34.8% for moderate anemia (23/66), and 10.6% for borderline anemia (7/66). More than half (64/70) of the children had microcytic anemia, while 8.6% (6/70) had normocytic anemia. About 40.0% (12/30) of the children had iron deficiency anemia, and 33.3 % (3/9) had sickle cell trait. Our results indicate that anemia rates were higher in male children aged 2-3 years, those whose caregivers had a low level of education, and those whose mothers were from the Community of Portuguese Language Countries. Further research, including analytical cross-sectional or longitudinal studies, is necessary to explore the impact of feeding practices, dietary habits, and socioeconomic and metabolic factors on childhood anemia.
- 11 September 2024
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (1) , e28-e29
Atypical Schistosomiasis and Strongyloidiasis Enterocolitis Mimicking Inflammatory Bowel Disease
- 11 September 2024
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (1) , e28-e29
Atypical Schistosomiasis and Strongyloidiasis Enterocolitis Mimicking Inflammatory Bowel Disease
- 11 July 2024
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 24 (16) , 2
Paediatric Palliative Care in a Reference Centre of Inherited Metabolic Diseases
Introduction: Paediatric palliative care (PPC) has a significant role in improving the quality of life of children with life-limiting or life-threatening illnesses, diminishing symptom burden, and providing holistic support to patients and families. Inherited metabolic diseases (IMD) are a group of heterogeneous diseases that often present with severe neurologic impairment, needing lifelong care and challenging symptom management. Objective: Our aim was to characterize the cohort of patients with IMD followed by the paediatric palliative care team (PPCT) and to describe the provision of care provided. Methods: The descriptive analysis of demographic, clinical, and care delivery data of a cohort of paediatric patients was carried out with a confirmed diagnosis of IMD, followed in a Reference Centre, in the care of PPCT between 2018 and 2023. Results: Thirteen (10%) of a total of 134 patients in the care of PPCT had a confirmed diagnosis of an IMD: 6 mitochondrial, 3 peroxisomal, 3 lysosomal, and 1 pterin metabolism disorder. The median age at referral was 9 years (0-18), the median duration of care was 2 years [2-4], median number of home visits in the last year was 2 [1-4], and median number of outpatient consults was 4 [2 -8]. Twelve patients (92%) had no autonomy in their activities of daily living. Neurologic (100%), gastrointestinal (92%), and respiratory (69%) symptoms were the main focus of care. All patients were polymedicated (5 or more different drugs). Nine (69%) had percutaneous gastrostomy and 2 (15%) had noninvasive ventilation. Median hospital admissions before and after starting care by PPCT were 4 and 1. Moreover, three patients died and one was at home. Conclusion: Mitochondrial, lysosomal, and peroxisomal disorders are complex multisystemic diseases that very often have no treatment intended to cure. These patients have a heavy symptom burden and frequent intercurrences. Addressing these symptoms is challenging, but PPC has proven to reduce hospital admissions with consequent improvement in quality of life. In the future, PPC should be available for all children and families with life-threatening conditions.
- 11 July 2024
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 24 (16) , 2
Paediatric Palliative Care in a Reference Centre of Inherited Metabolic Diseases
Introduction: Paediatric palliative care (PPC) has a significant role in improving the quality of life of children with life-limiting or life-threatening illnesses, diminishing symptom burden, and providing holistic support to patients and families. Inherited metabolic diseases (IMD) are a group of heterogeneous diseases that often present with severe neurologic impairment, needing lifelong care and challenging symptom management. Objective: Our aim was to characterize the cohort of patients with IMD followed by the paediatric palliative care team (PPCT) and to describe the provision of care provided. Methods: The descriptive analysis of demographic, clinical, and care delivery data of a cohort of paediatric patients was carried out with a confirmed diagnosis of IMD, followed in a Reference Centre, in the care of PPCT between 2018 and 2023. Results: Thirteen (10%) of a total of 134 patients in the care of PPCT had a confirmed diagnosis of an IMD: 6 mitochondrial, 3 peroxisomal, 3 lysosomal, and 1 pterin metabolism disorder. The median age at referral was 9 years (0-18), the median duration of care was 2 years [2-4], median number of home visits in the last year was 2 [1-4], and median number of outpatient consults was 4 [2 -8]. Twelve patients (92%) had no autonomy in their activities of daily living. Neurologic (100%), gastrointestinal (92%), and respiratory (69%) symptoms were the main focus of care. All patients were polymedicated (5 or more different drugs). Nine (69%) had percutaneous gastrostomy and 2 (15%) had noninvasive ventilation. Median hospital admissions before and after starting care by PPCT were 4 and 1. Moreover, three patients died and one was at home. Conclusion: Mitochondrial, lysosomal, and peroxisomal disorders are complex multisystemic diseases that very often have no treatment intended to cure. These patients have a heavy symptom burden and frequent intercurrences. Addressing these symptoms is challenging, but PPC has proven to reduce hospital admissions with consequent improvement in quality of life. In the future, PPC should be available for all children and families with life-threatening conditions.
- 31 March 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (4) , 283-290
Clinical and Therapeutic Approach to Hospitalized COVID-19 Patients: A Pediatric Cohort in Portugal
Clinical and Therapeutic Approach to Hospitalized COVID-19 Patients: A Pediatric Cohort in Portugal
- 31 March 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (4) , 283-290
Clinical and Therapeutic Approach to Hospitalized COVID-19 Patients: A Pediatric Cohort in Portugal
Clinical and Therapeutic Approach to Hospitalized COVID-19 Patients: A Pediatric Cohort in Portugal
- Open Access
- 29 March 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (3) , e241111
Acute haemorrhagic oedema of infancy as a manifestation of COVID-19
Several cutaneous manifestations have been seen to be associated with SARS-CoV-2 infection since the beginning of the pandemic.1–3 Acute haemorrhagic oedema of infancy (AHEI) is a vasculitis that is expressed in the first 2 years of life; it is characterised by purpuric lesions in the face, arms and legs, and is associated with oedema of the extremities. The intensity of the lesions contrasts with the benign course and good prognosis of this disease.4 5
- 29 March 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (3) , e241111
Open AccessAcute haemorrhagic oedema of infancy as a manifestation of COVID-19
Several cutaneous manifestations have been seen to be associated with SARS-CoV-2 infection since the beginning of the pandemic.1–3 Acute haemorrhagic oedema of infancy (AHEI) is a vasculitis that is expressed in the first 2 years of life; it is characterised by purpuric lesions in the face, arms and legs, and is associated with oedema of the extremities. The intensity of the lesions contrasts with the benign course and good prognosis of this disease.4 5